48 related articles for article (PubMed ID: 19650189)
1. E-cadherin, b-catenin and topoisomerase II expression in rhabdomyosarcomas.
Gogou PN; Batistatou A; Pakos EE; Apostolikas N; Stefanou D; Tsekeris PG
J BUON; 2009; 14(2):323-4. PubMed ID: 19650189
[No Abstract] [Full Text] [Related]
2. Clinicopathologic study of E-cadherin/beta-catenin complex, and topoisomerase-II in a series of 71 liposarcoma cases.
Gogou P; Pakos E; Batistatou A; Panelos I; Briasoulis E; Stefanou D; Apostolikas N; Tsekeris P
World J Surg Oncol; 2012 Feb; 10():28. PubMed ID: 22300273
[TBL] [Abstract][Full Text] [Related]
3. [The specific features of the expression of E-cadherin and beta-catenin in adenomyosis].
Gorbacheva IuV; Romadanova IuA; Solomakhina MA; Popova OP; Voloshchuk IN
Arkh Patol; 2008; 70(5):12-6. PubMed ID: 19137776
[TBL] [Abstract][Full Text] [Related]
4. Expression of E-cadherin, beta-catenin and APC protein in canine colorectal tumours.
Restucci B; Martano M; DE Vico G; Lo Muzio L; Maiolino P
Anticancer Res; 2009 Aug; 29(8):2919-25. PubMed ID: 19661296
[TBL] [Abstract][Full Text] [Related]
5. Expression of cadherin/catenin cell--cell adhesion molecules in a onychomatricoma.
Burchette JL; Pham TT; Higgins SP; Cook JL; Soler AP
Int J Surg Pathol; 2008 Jul; 16(3):349-53. PubMed ID: 18573792
[TBL] [Abstract][Full Text] [Related]
6. Expression of E-cadherin, beta-catenin and topoisomerase IIalpha in leiomyosarcomas.
Gogou PN; Batistatou A; Pakos EE; Apostolikas N; Stefanou D; Tsekeris PG
Clin Transl Oncol; 2009 Aug; 11(8):548-51. PubMed ID: 19661031
[TBL] [Abstract][Full Text] [Related]
7. Decreased expression of E-cadherin and beta-catenin in the lesional skin of patients with active psoriasis.
Li Z; Peng Z; Wang Y; Geng S; Ji F
Int J Dermatol; 2008 Feb; 47(2):207-9. PubMed ID: 18211502
[No Abstract] [Full Text] [Related]
8. In vitro assessment of novel transcription inhibitors and topoisomerase poisons in rhabdomyosarcoma cell lines.
Wolf SJ; Wakelin LP; He Z; Stewart BW; Catchpoole DR
Cancer Chemother Pharmacol; 2009 Nov; 64(6):1059-69. PubMed ID: 19277661
[TBL] [Abstract][Full Text] [Related]
9. E-cadherin/beta-catenin and CD10: a limited immunohistochemical panel to distinguish pancreatic endocrine neoplasm from solid pseudopapillary neoplasm of the pancreas on endoscopic ultrasound-guided fine-needle aspirates of the pancreas.
Burford H; Baloch Z; Liu X; Jhala D; Siegal GP; Jhala N
Am J Clin Pathol; 2009 Dec; 132(6):831-9. PubMed ID: 19926573
[TBL] [Abstract][Full Text] [Related]
10. Reduced gamma-catenin expression and poor survival in oral squamous cell carcinoma.
Närkiö-Mäkelä M; Pukkila M; Lagerstedt E; Virtaniemi J; Pirinen R; Johansson R; Kosunen A; Lappalainen K; Hämäläinen K; Kosma VM
Arch Otolaryngol Head Neck Surg; 2009 Oct; 135(10):1035-40. PubMed ID: 19841345
[TBL] [Abstract][Full Text] [Related]
11. Cationic porphyrins and analogues as new DNA topoisomerase I and II inhibitors.
Shuai L; Wang S; Zhang L; Fu B; Zhou X
Chem Biodivers; 2009 Jun; 6(6):827-37. PubMed ID: 19551725
[TBL] [Abstract][Full Text] [Related]
12. Novel nitro-oxy derivatives of celecoxib for the regulation of colon cancer cell growth.
Bozzo F; Bassignana A; Lazzarato L; Boschi D; Gasco A; Bocca C; Miglietta A
Chem Biol Interact; 2009 Dec; 182(2-3):183-90. PubMed ID: 19682443
[TBL] [Abstract][Full Text] [Related]
13. The epithelial-mesenchymal transition: fact or fiction in cancer?
Giannelli G
Hepatology; 2009 Nov; 50(5):1344-6. PubMed ID: 19877297
[No Abstract] [Full Text] [Related]
14. Analysis of the interaction of BCL9 with beta-catenin and development of fluorescence polarization and surface plasmon resonance binding assays for this interaction.
Kawamoto SA; Thompson AD; Coleska A; Nikolovska-Coleska Z; Yi H; Wang S
Biochemistry; 2009 Oct; 48(40):9534-41. PubMed ID: 19715304
[TBL] [Abstract][Full Text] [Related]
15. beta-Catenin/TCF/LEF1 can directly regulate phenylephrine-induced cell hypertrophy and Anf transcription in cardiomyocytes.
Zhang CG; Jia ZQ; Li BH; Zhang H; Liu YN; Chen P; Ma KT; Zhou CY
Biochem Biophys Res Commun; 2009 Dec; 390(2):258-62. PubMed ID: 19799869
[TBL] [Abstract][Full Text] [Related]
16. PDZ-domain-directed basolateral targeting of the peripheral membrane protein FRMPD2 in epithelial cells.
Stenzel N; Fetzer CP; Heumann R; Erdmann KS
J Cell Sci; 2009 Sep; 122(Pt 18):3374-84. PubMed ID: 19706687
[TBL] [Abstract][Full Text] [Related]
17. CD24 is a novel predictor for poor prognosis of hepatocellular carcinoma after surgery.
Yang XR; Xu Y; Yu B; Zhou J; Li JC; Qiu SJ; Shi YH; Wang XY; Dai Z; Shi GM; Wu B; Wu LM; Yang GH; Zhang BH; Qin WX; Fan J
Clin Cancer Res; 2009 Sep; 15(17):5518-27. PubMed ID: 19706825
[TBL] [Abstract][Full Text] [Related]
18. Calcium/calmodulin-dependent protein kinase type IV is a target gene of the Wnt/beta-catenin signaling pathway.
Arrázola MS; Varela-Nallar L; Colombres M; Toledo EM; Cruzat F; Pavez L; Assar R; Aravena A; González M; Montecino M; Maass A; Martínez S; Inestrosa NC
J Cell Physiol; 2009 Dec; 221(3):658-67. PubMed ID: 19711354
[TBL] [Abstract][Full Text] [Related]
19. Retinoic acid receptor antagonists inhibit miR-10a expression and block metastatic behavior of pancreatic cancer.
Weiss FU; Marques IJ; Woltering JM; Vlecken DH; Aghdassi A; Partecke LI; Heidecke CD; Lerch MM; Bagowski CP
Gastroenterology; 2009 Dec; 137(6):2136-45.e1-7. PubMed ID: 19747919
[TBL] [Abstract][Full Text] [Related]
20. [Regulation of neuronal gene expression by DNA topoisomerase IIbeta].
Tsutsui K; Tsutsui KM; Miyaji M; Sano K
Tanpakushitsu Kakusan Koso; 2009 Sep; 54(11):1333-43. PubMed ID: 19764468
[No Abstract] [Full Text] [Related]
[Next] [New Search]
